We are live on
!
Find out more
ProShare Advisors Portfolio holdings
AUM
$67.5B
1-Year Est. Return
28.09%
This Quarter
Est. Return
+4.79%
1 Year Est. Return
+28.09%
3 Year Est. Return
+88.43%
5 Year Est. Return
+118.21%
10 Year Est. Return
+464.8%
AUM
$10.9B
AUM Growth
+$843M
(+8.4%)
Cap. Flow
+$426M
Cap. Flow
% of AUM
3.92%
Top 10 Holdings %
Top 10 Hldgs %
16.38%
Holding
1,453
New
18
Increased
663
Reduced
669
Closed
101
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$32.9M |
| 2 |
Microsoft
MSFT
|
+$24.3M |
| 3 |
Amazon
AMZN
|
+$21.5M |
| 4 |
Meta Platforms (Facebook)
META
|
+$17.4M |
| 5 |
DuPont de Nemours
DD
|
+$16.9M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
DD
Du Pont De Nemours E I
DD
|
+$16.3M |
| 2 |
BCR
CR Bard Inc.
BCR
|
+$13.1M |
| 3 |
A.O. Smith
AOS
|
+$9.9M |
| 4 |
S&P Global
SPGI
|
+$8.24M |
| 5 |
AbbVie
ABBV
|
+$6.58M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 14.75% |
| 2 | Financials | 14.74% |
| 3 | Technology | 14.3% |
| 4 | Consumer Staples | 10.87% |
| 5 | Industrials | 10.16% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1276
Nexstar Media Group
NXST
$5.37B
| $208K | ﹤0.01% |
3,334
-682
| -17% | -$42.1K |
|
|
LPNT
1277
DELISTED
LifePoint Health, Inc.
LPNT
| $208K | ﹤0.01% |
3,600
-132
| -4% | -$7.85K |
|
|
TIVO
1278
DELISTED
Tivo Inc
TIVO
| $207K | ﹤0.01% |
10,447
-1,734
| -14% | -$32.4K |
|
1279
Veeva Systems
VEEV
$29.5B
| $206K | ﹤0.01% |
3,648
-248
| -6% | -$15K |
|
1280
DNOW Inc
DNOW
$2.61B
| $205K | ﹤0.01% |
14,836
-2,749
| -16% | -$37.5K |
|
1281
Unifirst Corp
UNF
$5.26B
| $205K | ﹤0.01% |
1,352
-231
| -15% | -$32.7K |
|
1282
Clean Harbors
CLH
$16.2B
| $204K | ﹤0.01% |
3,599
-314
| -8% | -$17.1K |
|
1283
Hope Bancorp
HOPE
$1.7B
| $202K | ﹤0.01% |
11,425
-4,112
| -26% | -$70.3K |
|
|
SGI
1284
Somnigroup International
SGI
$14.4B
| $202K | ﹤0.01% |
+12,548
| New | +$185K |
|
1285
Green Dot
GDOT
$743M
| $200K | ﹤0.01% |
+4,028
| New | +$179K |
|
1286
Rigel Pharmaceuticals
RIGL
$700M
| $200K | ﹤0.01% |
7,870
+493
| +7% | +$12K |
|
|
TGNA
1287
DELISTED
TEGNA Inc
TGNA
| $200K | ﹤0.01% |
14,979
-1,153
| -7% | -$15.5K |
|
1288
Minerva Neurosciences
NERV
$210M
| $197K | ﹤0.01% |
3,243
+610
| +23% | +$35K |
|
1289
Wendy's
WEN
$1.37B
| $194K | ﹤0.01% |
12,466
-1,640
| -12% | -$25.1K |
|
1290
Collegium Pharmaceutical
COLL
$1.15B
| $191K | ﹤0.01% |
18,213
+1,088
| +6% | +$12K |
|
1291
Neurogene
NGNE
$714M
| $188K | ﹤0.01% |
661
+60
| +10% | +$17.2K |
|
1292
Cerus
CERS
$577M
| $187K | ﹤0.01% |
68,562
+5,625
| +9% | +$13.8K |
|
|
MDR
1293
DELISTED
McDermott International
MDR
| $185K | ﹤0.01% |
8,484
-1,427
| -14% | -$28.6K |
|
|
LUMO
1294
DELISTED
Lumos Pharma, Inc. Common Stock
LUMO
| $184K | ﹤0.01% |
2,008
+126
| +7% | +$9.66K |
|
1295
Arrowhead Research
ARWR
$12.4B
| $182K | ﹤0.01% |
42,114
+3,734
| +10% | +$8.89K |
|
1296
Knowles
KN
$3.16B
| $180K | ﹤0.01% |
11,760
-2,198
| -16% | -$33.8K |
|
1297
Iridium Communications
IRDM
$4.98B
| $177K | ﹤0.01% |
17,210
-5,998
| -26% | -$62.2K |
|
|
SRCI
1298
DELISTED
SRC Energy Inc
SRCI
| $171K | ﹤0.01% |
17,728
-4,211
| -19% | -$33.2K |
|
|
PETX
1299
DELISTED
Aratana Therapeutics, Inc.
PETX
| $166K | ﹤0.01% |
27,007
+1,685
| +7% | +$10.7K |
|
|
WLL
1300
DELISTED
Whiting Petroleum Corporation
WLL
| $165K | ﹤0.01% |
101
+6
| +6% | +$8.82K |
|
Similar funds
ProShare Advisors's Q3 2017 Portfolio in Review
As of Q3 2017, ProShare Advisors held 1,453 positions worth $10.9B, up 8.4% from $10B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
ProShare Advisors deployed $426M of net new capital in Q3 2017, opening 18 new positions and adding to 663 existing holdings. Its largest new stake was Baker Hughes: 116,604 shares worth $4.27M.
By sector, the portfolio is most concentrated in Healthcare at 15% of assets, down from 15% a quarter earlier, followed by Financials and Technology.
On the sell side, the largest reduction was CR Bard Inc., an estimated $13.1M trimmed.
- ProShare Advisors's largest Q3 2017 buy was Baker Hughes: 116,604 shares worth $4.27M.
- ProShare Advisors added most to Apple in Q3 2017, an estimated $32.9M increase.
- ProShare Advisors's biggest Q3 2017 reduction was CR Bard Inc., cutting an estimated $13.1M.
- ProShare Advisors fully exited Du Pont De Nemours E I in Q3 2017, selling an estimated $16.3M.
- ProShare Advisors's ten largest holdings make up 16% of its $10.9B portfolio in Q3 2017.
- ProShare Advisors opened 18 new positions and closed 101 in Q3 2017.
- ProShare Advisors's portfolio value rose 8.4% quarter-over-quarter to $10.9B.
Based on ProShare Advisors's 13F filing for Q3 2017, filed 13 Nov 2017.